Randomized, Placebo-Controlled, Phase 2 Study Of Induction Chemotherapy With Cisplatin/Carboplatin, And Docetaxel With Or Without Erlotinib In Patients With Head And Neck Squamous Cell Carcinomas Amenable For Surgical Resection
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Erlotinib (Primary) ; Carboplatin; Cisplatin; Docetaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 31 May 2016 Status changed from active, no longer recruiting to recruiting.
- 24 May 2016 Status changed from recruiting to active, no longer recruiting.
- 19 Dec 2013 Status changed from not yet recruiting to recruiting as reported by M.D. Anderson Cancer Center.